-
Polysubstance Use Is Rewriting the Rules of Addiction Medicine
Key Takeaways: Fentanyl increasingly contains sedative adulterants like xylazine and medetomidine, plus stimulants, which is complicating standard opioid use disorder treatment protocols. Xylazine's own withdrawal syndrome and its masking of opioid withdrawal signs are pushing providers...
-
Technology Revives the Forgotten “Secret Weapon” Addiction Treatment Needs Now
What if I told you that one of the most powerful and evidence-based clinical interventions for substance use disorder was nearly abandoned and forgotten? It’s true. With the opioid epidemic raging, the stimulant epidemic on the rise, and the COVID-19 pandemic exacerbating behavioral health...
